000			01814 a2200481 4500
005			20250513110929.0
264		0	_c19970211
008			199702s 0 0 eng d
022			_a0735-1097
024	7		_a10.1016/s0735-1097(96)00448-2 _2doi
040			_aNLM _beng _cNLM
100	1		_aSeto, T B
245	0	0	_aCost-effectiveness of transesophageal echocardiographic-guided cardioversion: a decision analytic model for patients admitted to the hospital with atrial fibrillation. _h[electronic resource]
260			_bJournal of the American College of Cardiology _cJan 1997
300			_a122-30 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAged
650	0	4	_aAnticoagulants _xtherapeutic use
650	0	4	_aAtrial Fibrillation _xeconomics
650	0	4	_aCerebrovascular Disorders _xepidemiology
650	0	4	_aCost-Benefit Analysis
650	0	4	_aCosts and Cost Analysis
650	0	4	_aDecision Support Techniques
650	0	4	_aEchocardiography _xeconomics
650	0	4	_aEchocardiography, Transesophageal _xeconomics
650	0	4	_aElectric Countershock _xeconomics
650	0	4	_aFemale
650	0	4	_aHeart Diseases _xdiagnostic imaging
650	0	4	_aHemorrhage _xchemically induced
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aQuality-Adjusted Life Years
650	0	4	_aRisk Factors
650	0	4	_aSensitivity and Specificity
650	0	4	_aThrombosis _xdiagnostic imaging
650	0	4	_aTime Factors
650	0	4	_aWarfarin _xtherapeutic use
700	1		_aTaira, D A
700	1		_aTsevat, J
700	1		_aManning, W J
773	0		_tJournal of the American College of Cardiology _gvol. 29 _gno. 1 _gp. 122-30
856	4	0	_uhttps://doi.org/10.1016/s0735-1097(96)00448-2 _zAvailable from publisher's website
999			_c8987508 _d8987508